In the i.c.v. insulin studies, we found that pre‐microinjection resting MAP trended towards being elevated in T2DM relative to controls (for ANOVA group × time interaction: P = 0.047, time: P = 0.171, group: P = 0.360). Here, INS is linked to type 2 diabetes mellitus.